$CVI
CVR ENERGY INC

2024 Q2 Form 10-Q Financial Statement

#000137613924000031 Filed on April 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $1.967B $1.863B $2.202B
YoY Change -12.03% -18.5% -17.84%
Cost Of Revenue $1.910B $1.702B $2.043B
YoY Change -3.49% -11.12% -14.59%
Gross Profit $57.00M $161.0M $159.0M
YoY Change -77.82% -56.6% -44.79%
Gross Profit Margin 2.9% 8.64% 7.22%
Selling, General & Admin $28.00M $36.00M $34.00M
YoY Change -12.5% -7.69% -12.82%
% of Gross Profit 49.12% 22.36% 21.38%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $72.00M $76.00M $1.000M
YoY Change -1.37% 11.76% -98.63%
% of Gross Profit 126.32% 47.2% 0.63%
Operating Expenses $28.00M $37.00M $35.00M
YoY Change -15.15% -5.13% -14.63%
Operating Profit $27.00M $124.0M $124.0M
YoY Change -87.95% -62.42% -49.8%
Interest Expense -$19.00M -$20.00M -$9.000M
YoY Change 18.75% 11.11% -50.0%
% of Operating Profit -70.37% -16.13% -7.26%
Other Income/Expense, Net $4.000M $4.000M $4.000M
YoY Change 0.0% 33.33% 0.0%
Pretax Income $12.00M $107.0M $119.0M
YoY Change -94.34% -66.03% -46.64%
Income Tax -$26.00M $17.00M $22.00M
% Of Pretax Income -216.67% 15.89% 18.49%
Net Earnings $21.00M $82.00M $91.00M
YoY Change -83.85% -57.95% -18.75%
Net Earnings / Revenue 1.07% 4.4% 4.13%
Basic Earnings Per Share $0.21 $0.81
Diluted Earnings Per Share $0.21 $0.82 $0.91
COMMON SHARES
Basic Shares Outstanding 100.5M shares 100.5M shares 100.5M shares
Diluted Shares Outstanding 100.5M shares 100.5M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $586.0M $644.0M $581.0M
YoY Change -21.97% 7.15% 13.92%
Cash & Equivalents $586.0M $644.0M $581.0M
Short-Term Investments
Other Short-Term Assets $29.00M $57.00M $110.0M
YoY Change -59.15% -41.24% 8.91%
Inventory $543.0M $601.0M $604.0M
Prepaid Expenses $36.00M $36.00M $59.00M
Receivables $298.0M $253.0M $286.0M
Other Receivables $0.00 $0.00 $598.0M
Total Short-Term Assets $1.492B $1.555B $2.179B
YoY Change -9.36% -5.01% 36.79%
LONG-TERM ASSETS
Property, Plant & Equipment $2.192B $2.210B $2.221B
YoY Change -1.92% -1.38% -1.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $96.00M $98.00M $100.0M
YoY Change -5.88% -4.85% 31.58%
Other Assets $319.0M $328.0M $307.0M
YoY Change -5.06% -0.61% 10.04%
Total Long-Term Assets $2.511B $2.538B $2.528B
YoY Change -2.33% -1.28% 0.08%
TOTAL ASSETS
Total Short-Term Assets $1.492B $1.555B $2.179B
Total Long-Term Assets $2.511B $2.538B $2.528B
Total Assets $4.003B $4.093B $4.707B
YoY Change -5.07% -2.73% 14.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $523.0M $551.0M $530.0M
YoY Change 12.23% 7.62% 6.64%
Accrued Expenses $115.0M $106.0M $129.0M
YoY Change -20.14% -17.19% -11.03%
Deferred Revenue $8.000M $20.00M $16.00M
YoY Change 14.29% -55.56% -66.67%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $8.000M $8.000M $606.0M
YoY Change 14.29% 33.33% 10000.0%
Total Short-Term Liabilities $1.022B $1.043B $1.682B
YoY Change -20.47% -22.57% 16.89%
LONG-TERM LIABILITIES
Long-Term Debt $1.576B $1.577B $1.579B
YoY Change -0.51% -0.44% -0.38%
Other Long-Term Liabilities $86.00M $84.00M $81.00M
YoY Change -12.24% -13.4% 47.27%
Total Long-Term Liabilities $1.940B $1.661B $1.987B
YoY Change 15.34% -14.03% 5.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.022B $1.043B $1.682B
Total Long-Term Liabilities $1.940B $1.661B $1.987B
Total Liabilities $2.962B $3.214B $3.669B
YoY Change -14.44% -1.98% 10.25%
SHAREHOLDERS EQUITY
Retained Earnings -$658.0M -$628.0M -$660.0M
YoY Change -12.5% -24.52% -32.38%
Common Stock $1.509B $1.509B $1.509B
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $849.0M $879.0M $847.0M
YoY Change
Total Liabilities & Shareholders Equity $4.003B $4.093B $4.707B
YoY Change -5.07% -2.73% 14.28%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $21.00M $82.00M $91.00M
YoY Change -83.85% -57.95% -18.75%
Depreciation, Depletion And Amortization $72.00M $76.00M $1.000M
YoY Change -1.37% 11.76% -98.63%
Cash From Operating Activities $81.00M $177.0M -$36.00M
YoY Change -77.93% -28.34% -136.36%
INVESTING ACTIVITIES
Capital Expenditures $75.00M $59.00M $59.00M
YoY Change -22.68% 11.32% 7.27%
Acquisitions
YoY Change
Other Investing Activities $1.000M $4.000M $1.000M
YoY Change 0.0% -78.95% 0.0%
Cash From Investing Activities -$74.00M -$55.00M -$58.00M
YoY Change -22.92% 61.76% 7.41%
FINANCING ACTIVITIES
Cash Dividend Paid $50.00M
YoY Change 0.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $600.0M
YoY Change
Cash From Financing Activities -65.00M -664.0M 384.0M
YoY Change -46.28% 444.26% -350.98%
NET CHANGE
Cash From Operating Activities 81.00M 177.0M -36.00M
Cash From Investing Activities -74.00M -55.00M -58.00M
Cash From Financing Activities -65.00M -664.0M 384.0M
Net Change In Cash -58.00M -542.0M 290.0M
YoY Change -138.67% -695.6% -368.52%
FREE CASH FLOW
Cash From Operating Activities $81.00M $177.0M -$36.00M
Capital Expenditures $75.00M $59.00M $59.00M
Free Cash Flow $6.000M $118.0M -$95.00M
YoY Change -97.78% -39.18% -315.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
75000000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
1702000000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
1915000000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39000000 usd
CY2024Q1 us-gaap Revenues
Revenues
1863000000 usd
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2024Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2024Q1 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations
CY2023Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations
CY2024Q1 us-gaap Cost Direct Material
CostDirectMaterial
1463000000 usd
CY2024Q1 us-gaap Direct Operating Costs
DirectOperatingCosts
164000000 usd
CY2023Q1 us-gaap Direct Operating Costs
DirectOperatingCosts
169000000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
66000000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
36000000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1000000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2000000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1000000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
123000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
330000000 usd
CY2024Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-20000000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-18000000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
107000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
315000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
56000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
90000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
259000000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
64000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
82000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
195000000 usd
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.81
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.94
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.94
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100500000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100500000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100500000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100500000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1038000000 usd
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
50000000 usd
CY2024Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
11000000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1067000000 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
791000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
259000000 usd
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
50000000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
70000000 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
1000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
929000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
90000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
259000000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
76000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
68000000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5000000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3000000 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-1000000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
10000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
9000000 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-24000000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
32000000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3000000 usd
CY2024Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
3000000 usd
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2000000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2000000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1000000 usd
CY2024Q1 cvi Increase Decrease In Current Assets Liabilities Net
IncreaseDecreaseInCurrentAssetsLiabilitiesNet
21000000 usd
CY2023Q1 cvi Increase Decrease In Current Assets Liabilities Net
IncreaseDecreaseInCurrentAssetsLiabilitiesNet
58000000 usd
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-1000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
2000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
177000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
247000000 usd
CY2024Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
47000000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
45000000 usd
CY2024Q1 cvi Payments For Turnaround Costs
PaymentsForTurnaroundCosts
12000000 usd
CY2023Q1 cvi Payments For Turnaround Costs
PaymentsForTurnaroundCosts
8000000 usd
CY2024Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
3000000 usd
CY2023Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
19000000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1000000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-55000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-34000000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
600000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
50000000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
50000000 usd
CY2024Q1 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
11000000 usd
CY2023Q1 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
70000000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-664000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-122000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-542000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
91000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1186000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
517000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
644000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
608000000 usd
CY2024Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="text-align:justify"><span style="color:#e5a70f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2) Basis of Presentation </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements, prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”), include the accounts of the Company and its majority-owned direct and indirect subsidiaries. All intercompany accounts and transactions have been eliminated. Certain notes and other information have been condensed or omitted from the condensed consolidated financial statements. Therefore, these condensed consolidated financial statements should be read in conjunction with the December 31, 2023 audited consolidated financial statements and notes thereto included in CVR Energy’s Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”).</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our condensed consolidated financial statements include the consolidated results of CVR Partners, which is defined as a variable interest entity (“VIE”). As the 100% owner of the general partner of CVR Partners, the Company has the sole ability to direct the activities that most significantly impact the economic performance of CVR Partners and is considered the primary beneficiary.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of the Company’s management, the accompanying condensed consolidated financial statements reflect all adjustments that are necessary for fair presentation of the financial position and results of operations of the Company for the periods presented. Such adjustments are of a normal recurring nature, unless otherwise disclosed. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements are prepared in conformity with GAAP, which requires management to make certain estimates and assumptions that affect the reported amounts and disclosure of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Results of operations and cash flows for the interim periods presented are not necessarily indicative of the results that will be realized for the year ending December 31, 2024 or any other interim or annual period.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements - Accounting Standards Issued But Not Yet Implemented</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740) - Improvements to Income Tax Disclosures, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which requires enhanced income tax disclosures that reflect how operations and related tax risks, as well as how tax planning and operational opportunities, affect the tax rate and prospects for future cash flows. This standard is effective for the Company’s annual period beginning January 1, 2025 with early adoption permitted. The Company is evaluating the effects of adopting this new accounting guidance on its disclosures but does not currently expect adoption will have a material impact on the Company’s consolidated financial statements. The Company does not intend to early adopt this ASU.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, FASB issued ASU 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which includes requirements for more robust disclosures of significant segment expenses and measures of a segment’s profit and loss used in assessing performance. This standard is effective for the Company’s annual period beginning January 1, 2024 and interim periods beginning January 1, 2025 and should be applied retrospectively to all comparative periods. Early adoption is permitted. The Company is still evaluating the effects of adopting this new accounting guidance on its disclosures.</span></div>
CY2024Q1 us-gaap Variable Interest Entity Ownership Percentage
VariableInterestEntityOwnershipPercentage
1
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
264000000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
260000000 usd
CY2024Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
199000000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
226000000 usd
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
39000000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
21000000 usd
CY2024Q1 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
99000000 usd
CY2023Q4 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
97000000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
601000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
604000000 usd
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
81000000 usd
CY2023Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
81000000 usd
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
4844000000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
4807000000 usd
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
2634000000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
2586000000 usd
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
2210000000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
2221000000 usd
CY2024Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1000000 usd
CY2023Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
2000000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
100000000 usd
CY2024Q1 cvi Cash Distributions From Equity Method Investment
CashDistributionsFromEquityMethodInvestment
6000000 usd
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
98000000 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
4000000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
4000000 usd
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1000000 usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1000000 usd
CY2024Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000000 usd
CY2023Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000000 usd
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
3000000 usd
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2000000 usd
CY2024Q1 cvi Accrued Renewable Fuel Standards Obligation Current
AccruedRenewableFuelStandardsObligationCurrent
294000000 usd
CY2023Q4 cvi Accrued Renewable Fuel Standards Obligation Current
AccruedRenewableFuelStandardsObligationCurrent
329000000 usd
CY2024Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
43000000 usd
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
47000000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
31000000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
51000000 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
22000000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
26000000 usd
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
21000000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
25000000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
20000000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
16000000 usd
CY2024Q1 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
19000000 usd
CY2023Q4 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
13000000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
15000000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14000000 usd
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
9000000 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10000000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
25000000 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
484000000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
546000000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
1577000000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
1579000000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
8000000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
606000000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
1585000000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
2185000000 usd
CY2024Q1 us-gaap Revenues
Revenues
1863000000 usd
CY2023Q1 us-gaap Revenues
Revenues
2286000000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3Y
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5000000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
12000000 usd
CY2023Q1 us-gaap Revenues
Revenues
2286000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
330000000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-18000000 usd
CY2024Q1 us-gaap Derivative Net Liability Position Aggregate Fair Value
DerivativeNetLiabilityPositionAggregateFairValue
9000000 usd
CY2024Q1 us-gaap Derivative Liability Fair Value Of Collateral
DerivativeLiabilityFairValueOfCollateral
0 usd
CY2024Q1 cvi Cash Cash Equivalents And Reserved Funds Carrying Value
CashCashEquivalentsAndReservedFundsCarryingValue
644000000 usd
CY2023Q4 cvi Cash Cash Equivalents And Reserved Funds Carrying Value
CashCashEquivalentsAndReservedFundsCarryingValue
1200000000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
1500000000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
2100000000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10000000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9000000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q1 us-gaap Revenues
Revenues
1863000000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
123000000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-20000000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
107000000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
76000000 usd
CY2024Q1 cvi Payments For Productive Assets Including Capital Expenditures Incurred But Not Yet Paid
PaymentsForProductiveAssetsIncludingCapitalExpendituresIncurredButNotYetPaid
51000000 usd
CY2023Q1 us-gaap Revenues
Revenues
2286000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
315000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
68000000 usd
CY2023Q1 cvi Payments For Productive Assets Including Capital Expenditures Incurred But Not Yet Paid
PaymentsForProductiveAssetsIncludingCapitalExpendituresIncurredButNotYetPaid
59000000 usd
CY2024Q1 us-gaap Assets
Assets
4093000000 usd
CY2023Q4 us-gaap Assets
Assets
4707000000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
26000000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4000000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
36000000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
29000000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
4000000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
4000000 usd
CY2024Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1000000 usd
CY2023Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1000000 usd
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2000000 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1000000 usd
CY2024Q1 cvi Increase Decrease In Accounts Payable Construction In Progress
IncreaseDecreaseInAccountsPayableConstructionInProgress
4000000 usd
CY2023Q1 cvi Increase Decrease In Accounts Payable Construction In Progress
IncreaseDecreaseInAccountsPayableConstructionInProgress
4000000 usd
CY2024Q1 cvi Increase Decrease In Accounts Payable Turnaround Expenditures
IncreaseDecreaseInAccountsPayableTurnaroundExpenditures
27000000 usd
CY2023Q1 cvi Increase Decrease In Accounts Payable Turnaround Expenditures
IncreaseDecreaseInAccountsPayableTurnaroundExpenditures
32000000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4000000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9000000 usd
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
644000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
581000000 usd
CY2024Q1 cvi Reserved Funds For Debt Payments
ReservedFundsForDebtPayments
0 usd
CY2024Q1 cvi Reserved Funds For Debt Payments
ReservedFundsForDebtPayments
0 usd
CY2023Q4 cvi Reserved Funds For Debt Payments
ReservedFundsForDebtPayments
598000000 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
7000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
644000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1186000000 usd
CY2024Q1 cvi Common Stock Dividends Per Share Cash Paid Related To Quarterly Results
CommonStockDividendsPerShareCashPaidRelatedToQuarterlyResults
0.50
CY2024Q1 cvi Common Stock Dividends Cash Paid Related To Quarterly Results
CommonStockDividendsCashPaidRelatedToQuarterlyResults
50000000 usd
CY2023Q1 cvi Common Stock Dividends Per Share Cash Paid Related To Quarterly Results
CommonStockDividendsPerShareCashPaidRelatedToQuarterlyResults
0.50
CY2023Q1 cvi Common Stock Dividends Cash Paid Related To Quarterly Results
CommonStockDividendsCashPaidRelatedToQuarterlyResults
50000000 usd
CY2023Q2 cvi Common Stock Dividends Per Share Cash Paid Related To Quarterly Results
CommonStockDividendsPerShareCashPaidRelatedToQuarterlyResults
0.50
CY2023Q2 cvi Common Stock Dividends Cash Paid Related To Quarterly Results
CommonStockDividendsCashPaidRelatedToQuarterlyResults
50000000 usd
CY2023Q3 cvi Common Stock Dividends Per Share Cash Paid Related To Quarterly Results
CommonStockDividendsPerShareCashPaidRelatedToQuarterlyResults
0.50
CY2023Q3 cvi Common Stock Dividends Cash Paid Related To Quarterly Results
CommonStockDividendsCashPaidRelatedToQuarterlyResults
50000000 usd
CY2023Q4 cvi Common Stock Dividends Per Share Cash Paid Related To Quarterly Results
CommonStockDividendsPerShareCashPaidRelatedToQuarterlyResults
0.50
CY2023Q4 cvi Common Stock Dividends Cash Paid Related To Quarterly Results
CommonStockDividendsCashPaidRelatedToQuarterlyResults
50000000 usd
CY2023 cvi Common Stock Dividends Per Share Cash Paid Related To Quarterly Results
CommonStockDividendsPerShareCashPaidRelatedToQuarterlyResults
2.00
CY2023 cvi Common Stock Dividends Cash Paid Related To Quarterly Results
CommonStockDividendsCashPaidRelatedToQuarterlyResults
201000000 usd
CY2023Q3 cvi Special Dividend Per Share Declared
SpecialDividendPerShareDeclared
1.00
CY2023Q3 cvi Special Dividends Value
SpecialDividendsValue
101000000 usd
CY2023Q4 cvi Special Dividend Per Share Declared
SpecialDividendPerShareDeclared
1.50
CY2023Q4 cvi Special Dividends Value
SpecialDividendsValue
151000000 usd
CY2023 cvi Special Dividend Per Share Declared
SpecialDividendPerShareDeclared
2.50
CY2023 cvi Special Dividends Value
SpecialDividendsValue
251000000 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001376139-24-000031-index-headers.html Edgar Link pending
0001376139-24-000031-index.html Edgar Link pending
0001376139-24-000031.txt Edgar Link pending
0001376139-24-000031-xbrl.zip Edgar Link pending
bonuspayoutexamplesa.jpg Edgar Link pending
corp-appendixc.jpg Edgar Link pending
corporate1-appendixb.jpg Edgar Link pending
corporate2-appendixb.jpg Edgar Link pending
cvi-20240331.htm Edgar Link pending
cvi-20240331.xsd Edgar Link pending
cvi-20240331_g1.gif Edgar Link pending
cvi-20240331_g10.jpg Edgar Link pending
cvi-20240331_g11.jpg Edgar Link pending
cvi-20240331_g12.jpg Edgar Link pending
cvi-20240331_g13.jpg Edgar Link pending
cvi-20240331_g14.jpg Edgar Link pending
cvi-20240331_g15.jpg Edgar Link pending
cvi-20240331_g16.jpg Edgar Link pending
cvi-20240331_g17.jpg Edgar Link pending
cvi-20240331_g18.jpg Edgar Link pending
cvi-20240331_g19.jpg Edgar Link pending
cvi-20240331_g2.jpg Edgar Link pending
cvi-20240331_g20.jpg Edgar Link pending
cvi-20240331_g21.jpg Edgar Link pending
cvi-20240331_g22.jpg Edgar Link pending
cvi-20240331_g23.jpg Edgar Link pending
cvi-20240331_g24.jpg Edgar Link pending
cvi-20240331_g25.jpg Edgar Link pending
cvi-20240331_g26.jpg Edgar Link pending
cvi-20240331_g27.jpg Edgar Link pending
cvi-20240331_g3.jpg Edgar Link pending
cvi-20240331_g4.jpg Edgar Link pending
cvi-20240331_g5.jpg Edgar Link pending
cvi-20240331_g6.jpg Edgar Link pending
cvi-20240331_g7.jpg Edgar Link pending
cvi-20240331_g8.jpg Edgar Link pending
cvi-20240331_g9.jpg Edgar Link pending
exhibit101-cvrenergyinc202.htm Edgar Link pending
cvi-20240331_cal.xml Edgar Link unprocessable
cvi-20240331_def.xml Edgar Link unprocessable
cvi-20240331_lab.xml Edgar Link unprocessable
cvi-20240331_pre.xml Edgar Link unprocessable
cvi-20240331_htm.xml Edgar Link completed
exhibit102-cvrpartnerslp20.htm Edgar Link pending
exhibit103-cvrenergyinc202.htm Edgar Link pending
exhibit311-cviq12024.htm Edgar Link pending
exhibit312-cviq12024.htm Edgar Link pending
exhibit313-cviq12024.htm Edgar Link pending
exhibit321-cviq12024.htm Edgar Link pending
fertilizer-appendixb1a.jpg Edgar Link pending
fertilizer-appendixb2a.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
refining-appendixb1.jpg Edgar Link pending
refining-appendixb2.jpg Edgar Link pending
refining-appendixc.jpg Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable